Ocugen Inc (OCGN)
0.9009
-0.02
(-1.92%)
USD |
NASDAQ |
Nov 21, 16:00
0.92
+0.02
(+2.12%)
After-Hours: 04:22
Ocugen Revenue (Quarterly): 1.136M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.136M |
| June 30, 2024 | 1.141M |
| March 31, 2024 | 1.014M |
| December 31, 2023 | 1.409M |
| September 30, 2023 | 3.699M |
| June 30, 2023 | 0.485M |
| March 31, 2023 | 0.443M |
| December 31, 2022 | 2.488M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 0.043M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | 0.003M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.043M
Minimum
Jun 2020
3.699M
Maximum
Sep 2023
1.318M
Average
1.136M
Median
Sep 2024
Revenue (Quarterly) Benchmarks
| Cytokinetics Inc | 0.463M |
| Scholar Rock Holding Corp | -- |
| Mirum Pharmaceuticals Inc | 90.38M |
| SpringWorks Therapeutics Inc | 49.30M |
| NeuroBo Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.97M |
| Total Expenses (Quarterly) | 14.39M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 226.64M |
| Profit Margin (Quarterly) | -1.14K% |
| Earnings Yield | -19.98% |
| Normalized Earnings Yield | -19.98 |